Deficiency of Cathelicidin Attenuates High-Fat Diet Plus Alcohol-Induced Liver Injury through FGF21/Adiponectin Regulation.
Deficiency of Cathelicidin Attenuates High-Fat Diet Plus Alcohol-Induced Liver Injury through FGF21/Adiponectin Regulation.
复制标题
作者:
Li F;Chen J;Liu Y;Gu Z;Jiang M;Zhang L;Chen SY;Deng Z;McClain CJ;Feng W
Alcohol consumption and obesity are known risk factors of steatohepatitis. Here, we report that the deficiency of CRAMP (cathelicidin-related antimicrobial peptide—gene name: Camp) is protective against a high-fat diet (HFD) plus acute alcohol (HFDE)-induced liver injury. HFDE markedly induced liver injury and steatosis in WT mice, which were attenuated in Camp–/– mice. Neutrophil infiltration was lessened in the liver of Camp–/– mice. HFDE feeding dramatically increased epididymal white adipose tissue (eWAT) mass and induced adipocyte hypertrophy in WT mice, whereas these effects were attenuated by the deletion of Camp. Furthermore, Camp–/– mice had significantly increased eWAT lipolysis, evidenced by up-regulated expression of lipolytic enzymes, adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL). The depletion of Camp also increased uncoupling protein 1 (UCP1)-dependent thermogenesis in the brown adipose tissue (BAT) of mice. HFDE fed Camp–/– mice had elevated protein levels of fibroblast growth factor 21 (FGF21) in the eWAT, with an increased adiponectin production, which had been shown to alleviate hepatic fat deposition and inflammation. Collectively, we have demonstrated that Camp–/– mice are protected against HFD plus alcohol-induced liver injury and steatosis through FGF21/adiponectin regulation. Targeting CRAMP could be an effective approach for prevention/treatment of high-fat diet plus alcohol consumption-induced steatohepatitis.
登录
查看更多内容
影响因子:
82.9
作者:
Arkan, MC;Hevener, AL;Karin, M
通讯作者:
Karin, M
影响因子:
5.6
作者:
Achari AE;Jain SK
通讯作者:
Jain SK
DOI:
10.1111/j.1530-0277.2011.01472.x
发表时间:
2011-07-01
影响因子:
3.2
作者:
Gaebele, Erwin;Dostert, Karin;Hellerbrand, Claus
通讯作者:
Hellerbrand, Claus
DOI:
10.1136/bmj.c1240
发表时间:
2010-03-11
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Hart CL;Morrison DS;Batty GD;Mitchell RJ;Davey Smith G
通讯作者:
Davey Smith G
影响因子:
7.7
作者:
Deng ZB;Poliakov A;Hardy RW;Clements R;Liu C;Liu Y;Wang J;Xiang X;Zhang S;Zhuang X;Shah SV;Sun D;Michalek S;Grizzle WE;Garvey T;Mobley J;Zhang HG
通讯作者:
Zhang HG